ANXA5 and infection: Following treatment with SM-AEG40730 (AEG40730), HIV-HSA-infected and HIV-HSA negative macrophages (uninfected, HIV exposed bystander macrophages) were analyzed for infection rate (% HSA + cells) and apoptosis as quantified by counter staining with Annexin-V labelled with BV711 expression.